Clinical Trial Update: Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness [Phase 3]

View source ↗

Summary

Phase 3 open-label trial update on the safety and efficacy of Tradipitant for motion sickness; the study is currently active, not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness

Drugs mentioned

• Tradipitant (tradipitant)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Motion Sickness | Phase 3 | Status: ACTIVE_NOT_RECRUITING